Who makes Skyrizi and where is it made?
Skyrizi is made by AbbVie Inc., a U.S. pharmaceutical company located in North Chicago, Illinois. They have multiple manufacturing plants, including ones in North Chicago, IL, Lake County, IL, Worcester, MA and Wyandotte, MI., as well as globally. You can contact AbbVie at 1-800-222-6885 or online at Abbvie.com.
When was Skyrizi approved?
In April 2019 the U.S. Food and Drug Administration (FDA) first approved Skyrizi (risankizumab-rzaa) for the treatment of plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
Skyrizi is also approved for adults to treat active psoriatic arthritis and Crohn's disease (both approved in 2022), and ulcerative colitis (approved in 2024).
Skyrizi is classified as an interleukin-23 (IL-23) inhibitor and helps to lower inflammation and improve symptoms in these autoimmune disorders.
What are Skyrizi's most common side effects?
Common side effects in plaque psoriasis and psoriatic arthritis include:
- upper respiratory infections
- headache
- fatigue
- injection site reactions
- tinea (fungal) infections.
In Crohn's disease, common side effects include upper respiratory infections, headache, and arthralgia (joint pain) during the induction period, and arthralgia, injection site reactions, abdominal pain, anemia (low red blood cells), pyrexia (fever), back pain, arthropathy (joint disease), and urinary tract infection during long-term, maintenance treatment.
In ulcerative colitis, side effects include arthralgia (joint pain) during the induction period and arthralgia, pyrexia (fever), injection site reactions, and rash during the maintenance phase of treatment.
Learn More: Skyrizi Uses and Safety Information
This is not all the information you need to know about Skyrizi (risankizumab-rzaa) for safe and effective use and does not take the place of your healthcare provider's directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.
Related questions
References
- Skyrizi (risankizumab-rzaa) prescribing information. AbbVie Inc. 6/2022. Accessed June 20, 2022 at https://www.rxabbvie.com/pdf/skyrizi_pi.pdf
- AbbVie. At a glance. Accessed June 19, 2024 at https://www.abbvie.pr/our-company/at-a-glance.html
Read next
Related medical questions
- What are the new drugs for plaque psoriasis?
- Why should I take folic acid with methotrexate?
- Is triamcinolone acetonide an antifungal cream?
- How do you use clobetasol propionate on your scalp?
- Clobetasol vs. triamcinolone - how do they compare?
- What is a substitute for fluocinonide cream?
- How long does methotrexate stay in your system?
- Halobetasol vs. clobetasol - How do they compare?
- Does taking vitamin D help with psoriasis?
- What causes Plaque Psoriasis?
- Sotyktu vs Otezla: How do they compare?
- Can clobetasol be used for toenail fungus?
- How does Taltz compare to Cosentyx for psoriatic arthritis?
- How long does it take for Skyrizi to work?
- How long does it take for Otezla to work?
- Is fluocinonide an antifungal cream?
- How long should you use fluocinonide for?
- How long does clobetasol stay in your system?
- How do you inject Humira?
- Does Feverfew interact with any drugs?
- What are 6 key Taltz side effects to watch out for?
- Cosentyx vs Humira: How do they compare?
- What's the dosing schedule for Skyrizi?
- Who is the actress in the Stelara commercial?
- What happens if Cosentyx is not refrigerated?
- Can Enstilar be used on the scalp?
- What does Otezla do to the body?
- What is fluocinonide cream good for?
- How long does it take for Sotyktu to work?
- What is the mechanism of action of infliximab?
Drug information
Related support groups
- Psoriasis (101 questions, 306 members)
- Skyrizi (17 questions, 6 members)
- Risankizumab (8 questions, 3 members)
- Psoriatic Arthritis (83 questions, 276 members)
- Plaque Psoriasis (85 questions, 69 members)
- Crohn's Disease (51 questions, 284 members)